209 related articles for article (PubMed ID: 31506395)
1. [Development of a Novel Treatment for Neurological Disorders by Drug Repositioning].
Saito S; Ihara M
Brain Nerve; 2019 Sep; 71(9):936-942. PubMed ID: 31506395
[TBL] [Abstract][Full Text] [Related]
2. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
Lanza V; Milardi D; Di Natale G; Pappalardo G
Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
[TBL] [Abstract][Full Text] [Related]
3. Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario.
Katare PB; Banerjee SK
Curr Top Med Chem; 2016; 16(19):2189-200. PubMed ID: 26881721
[TBL] [Abstract][Full Text] [Related]
4. Laying in silico pipelines for drug repositioning: a paradigm in ensemble analysis for neurodegenerative diseases.
Dovrolis N; Kolios G; Spyrou G; Maroulakou I
Drug Discov Today; 2017 May; 22(5):805-813. PubMed ID: 28363518
[TBL] [Abstract][Full Text] [Related]
5. Drug repositioning: re-investigating existing drugs for new therapeutic indications.
Padhy BM; Gupta YK
J Postgrad Med; 2011; 57(2):153-60. PubMed ID: 21654146
[TBL] [Abstract][Full Text] [Related]
6. Challenges and opportunities of drug repositioning.
Novac N
Trends Pharmacol Sci; 2013 May; 34(5):267-72. PubMed ID: 23582281
[TBL] [Abstract][Full Text] [Related]
7. A physarum-inspired prize-collecting steiner tree approach to identify subnetworks for drug repositioning.
Sun Y; Hameed PN; Verspoor K; Halgamuge S
BMC Syst Biol; 2016 Dec; 10(Suppl 5):128. PubMed ID: 28105946
[TBL] [Abstract][Full Text] [Related]
8. Novel insight into drug repositioning: Methylthiouracil as a case in point.
Baek MC; Jung B; Kang H; Lee HS; Bae JS
Pharmacol Res; 2015 Sep; 99():185-93. PubMed ID: 26117428
[TBL] [Abstract][Full Text] [Related]
9. Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.
Kobayashi Y; Banno K; Kunitomi H; Tominaga E; Aoki D
J Gynecol Oncol; 2019 Jan; 30(1):e10. PubMed ID: 30479094
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Drug Repositioning and Prediction Techniques: A Concise Review.
He S; Liu X; Ye X; Tetsuya S
Curr Top Med Chem; 2022; 22(23):1897-1906. PubMed ID: 35301952
[TBL] [Abstract][Full Text] [Related]
11. Serological biochemical markers of surrogate efficacy and safety as a novel approach to drug repositioning.
Henriksen K; Christiansen C; Karsdal MA
Drug Discov Today; 2011 Nov; 16(21-22):967-75. PubMed ID: 21745584
[TBL] [Abstract][Full Text] [Related]
12. A bidirectional drug repositioning approach for Parkinson's disease through network-based inference.
Rakshit H; Chatterjee P; Roy D
Biochem Biophys Res Commun; 2015 Feb; 457(3):280-7. PubMed ID: 25576361
[TBL] [Abstract][Full Text] [Related]
13. Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation.
Arbo BD; Schimith LE; Goulart Dos Santos M; Hort MA
Eur J Pharmacol; 2022 Mar; 919():174800. PubMed ID: 35131314
[TBL] [Abstract][Full Text] [Related]
14. Network mirroring for drug repositioning.
Park S; Lee DG; Shin H
BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
[TBL] [Abstract][Full Text] [Related]
15. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
Hameed PN; Verspoor K; Kusljic S; Halgamuge S
BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
[TBL] [Abstract][Full Text] [Related]
16. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
Zhao M; Yang CC
J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
[TBL] [Abstract][Full Text] [Related]
17. A systems-level analysis of drug-target-disease associations for drug repositioning.
Rutherford KD; Mazandu GK; Mulder NJ
Brief Funct Genomics; 2018 Jan; 17(1):34-41. PubMed ID: 28968683
[TBL] [Abstract][Full Text] [Related]
18. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
Cummings JL; Zhong K
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
[TBL] [Abstract][Full Text] [Related]
19. Insights into Computational Drug Repurposing for Neurodegenerative Disease.
Paranjpe MD; Taubes A; Sirota M
Trends Pharmacol Sci; 2019 Aug; 40(8):565-576. PubMed ID: 31326236
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel analgesics through a drug repurposing strategy.
Gazerani P
Pain Manag; 2019 Jul; 9(4):399-415. PubMed ID: 30950770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
